BBHC
Brown Brothers Harriman & Co Portfolio holdings
AUM $15.6B
1-Year Return
17.71%
This Quarter Return
+11.19%
1 Year Return
+17.71%
3 Year Return
+77.24%
5 Year Return
+124.29%
10 Year Return
+261.89%
AUM
$12B
AUM Growth
+$720M
(+6.4%)
Cap. Flow
-$493M
Cap. Flow
% of AUM
-4.09%
Top 10 Holdings %
Top 10 Hldgs %
40.42%
Holding
1,305
New
93
Increased
234
Reduced
410
Closed
156
Top Buys
| 1 |
UnitedHealth
UNH
|
+$136M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$43M |
| 3 |
American Water Works
AWK
|
+$13M |
| 4 |
Ecolab
ECL
|
+$12.8M |
| 5 |
Bruker
BRKR
|
+$10.3M |
Top Sells
| 1 |
Philip Morris
PM
|
+$104M |
| 2 |
Costco
COST
|
+$85.6M |
| 3 |
Copart
CPRT
|
+$73.1M |
| 4 |
TransDigm Group
TDG
|
+$65.7M |
| 5 |
KLA
KLAC
|
+$63.3M |
Sector Composition
| 1 | Financials | 20.74% |
| 2 | Technology | 20.4% |
| 3 | Healthcare | 14.83% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Discretionary | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Corpay
CPAY
$21.5B
| $6.01M | 0.05% |
21,263
-119
| -0.6% | -$33.6K |
|
127
Toro Company
TTC
$7.79B
| $5.97M | 0.05% |
62,143
+15,869
| +34% | +$1.52M |
|
128
Intel
INTC
$116B
| $5.94M | 0.05% |
118,191
-2,846
| -2% | -$143K |
|
129
Pfizer
PFE
$136B
| $5.9M | 0.05% |
204,870
-28,334
| -12% | -$816K |
|
130
Salesforce
CRM
$231B
| $5.83M | 0.05% |
22,166
+846
| +4% | +$223K |
|
131
Lowe's Companies
LOW
$153B
| $5.71M | 0.05% |
25,673
-1,283
| -5% | -$286K |
|
132
Vanguard FTSE Emerging Markets ETF
VWO
$101B
| $5.64M | 0.05% |
137,162
+983
| +0.7% | +$40.4K |
|
133
iShares Core S&P Mid-Cap ETF
IJH
$101B
| $5.59M | 0.05% |
100,855
-320
| -0.3% | -$17.7K |
|
134
Watts Water Technologies
WTS
$9.4B
| $5.45M | 0.05% |
26,143
-12,500
| -32% | -$2.6M |
|
135
Shell
SHEL
$208B
| $5.05M | 0.04% |
76,798
-510
| -0.7% | -$33.6K |
|
136
Intercontinental Exchange
ICE
$98.6B
| $5.05M | 0.04% |
39,339
-17,118
| -30% | -$2.2M |
|
137
Accenture
ACN
$148B
| $5.04M | 0.04% |
14,357
-801
| -5% | -$281K |
|
138
Starbucks
SBUX
$94B
| $5.02M | 0.04% |
52,305
-4,190
| -7% | -$402K |
|
139
Bristol-Myers Squibb
BMY
$94.3B
| $5.02M | 0.04% |
97,850
-2,267
| -2% | -$116K |
|
140
US Bancorp
USB
$76.7B
| $4.97M | 0.04% |
114,750
-16,347
| -12% | -$707K |
|
141
Cisco
CSCO
$265B
| $4.96M | 0.04% |
98,085
-8,876
| -8% | -$448K |
|
142
Novartis
NVS
$239B
| $4.87M | 0.04% |
48,247
-13,045
| -21% | -$1.32M |
|
143
Amgen
AMGN
$148B
| $4.8M | 0.04% |
16,656
+161
| +1% | +$46.4K |
|
144
Cabot Corp
CBT
$4.2B
| $4.75M | 0.04% |
56,902
| – | – |
|
145
iShares Russell 2000 ETF
IWM
$67.8B
| $4.65M | 0.04% |
23,149
-1,153
| -5% | -$231K |
|
146
Target
TGT
$40.2B
| $4.64M | 0.04% |
32,591
+217
| +0.7% | +$30.9K |
|
147
Kimberly-Clark
KMB
$41.6B
| $4.55M | 0.04% |
37,468
+134
| +0.4% | +$16.3K |
|
148
Emerson Electric
EMR
$76.3B
| $4.52M | 0.04% |
46,395
+643
| +1% | +$62.6K |
|
149
SPDR Gold Trust
GLD
$116B
| $4.45M | 0.04% |
23,298
+15
| +0.1% | +$2.87K |
|
150
Colgate-Palmolive
CL
$66.4B
| $4.43M | 0.04% |
55,550
-9,366
| -14% | -$747K |
|